Do you want to read an article? Please log in or register.
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
Multiple Sclerosis
RECOMMENDED
Related content
Multiple Sclerosis
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
JAMA Neurol.
Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R; Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group.
doi: 10.1001/
RECOMMENDED
Multiple Sclerosis
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Mult Scler.
Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, Benedict RH
doi: 10.1177/1352458519881428.
Multiple Sclerosis
Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study
J Neurol Neurosurg Psychiatry.
Crielaard L, Kavaliunas A, Ramanujam R, Olsson T, Hillert J, Stridh P, Kockum I, Manouchehrinia A
doi: 10.1136/jnnp-2018-319913.
RECOMMENDED
Aging and Cognitive FunctionsMultiple Sclerosis
Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis
Brain.
Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O
doi: 10.1093/brain/awz156.
RECOMMENDED
Stroke
NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke
Stroke.
Uphaus T, Bittner S, Gröschel S, Steffen F, Muthuraman M, Wasser K, Weber-Krüger M, Zipp F, Wachter R, Gröschel K
doi: 10.1161/
Multiple Sclerosis
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
Brain.
Rocca MA, Sormani MP, Rovaris M, Caputo D, Ghezzi A, Montanari E, Bertolotto A, Laroni A, Bergamaschi R, Martinelli V, Comi G, Filippi M
doi: 10.1093/brain/awx250.
Multiple Sclerosis
The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis
Mult Scler
Claflin SB, Campbell JA, Mason DF, Kalincik T, Simpson-Yap S, Norman R, Butzkueven H, Carroll WM, Palmer AJ, Blizzard CL, van der Mei I, Taylor BV
doi: 10.1177/13524585211035948
Multiple Sclerosis
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Mult Scler.
Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S
doi: 10.1177/1352458518765666.
Multiple Sclerosis
Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis
Ann Neurol.
Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J; Swiss MS Cohort Study (SMSC) Group
doi: 10.1002/ana.24954.